# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Abiomed (NASDAQ:ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP th...
S&P MidCap 400 constituent Steel Dynamics Inc. (NASD:STLD) will replace Abiomed Inc. (NASD:ABMD) in the S&P 500 and Sup...
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s t...
Johnson & Johnson (NYSE: JNJ), the world's largest, most diversified healthcare products company, today announced that ...
- Reuters